A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors.Published in:2017By:Tolcher, Anthony;Berlin, Jordan;Cosaert, Jan;Kauh, John;Chan, Emily;Piha-Paul, Sarina;Amaya, Alex;Tang, Shande;Driscoll, Kyla;Kimbung, Richard;Kambhampati, S.;Gueorguieva, Ivelina;Hong, David;Tolcher, Anthony W;Berlin, Jordan D;Piha-Paul, Sarina A;Kambhampati, S R Prasad;Hong, David SPublication type:journal article